Chronic thromboembolic disease and chronic thromboembolic pulmonary hypertension

…, R Sadushi-Kolici, R Badr-Eslam… - Clinics in chest …, 2021 - chestmed.theclinics.com
Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive pulmonary
vascular disease characterized by chronic obstruction of major pulmonary arteries with flow-…

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial

…, IM Lang, C Hengstenberg, R Badr-Eslam… - European heart …, 2022 - academic.oup.com
Aims The presence of pulmonary hypertension (PH) severely aggravates the clinical course
of heart failure with preserved ejection fraction (HFpEF). To date, neither established heart …

[HTML][HTML] Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement

…, T Weber, MM Zaruba, R Badr Eslam… - Wiener klinische …, 2020 - Springer
The prevalence and significance of cardiac amyloidosis have been considerably underestimated
in the past; however, the number of patients diagnosed with cardiac amyloidosis has …

Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy

…, D Beitzke, C Loewe, R Badr Eslam… - European Heart …, 2023 - academic.oup.com
Aims Tafamidis treatment positively affects left ventricular (LV) structure and function and
improves outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). We …

Impact of tafamidis and optimal background treatment on physical performance in patients with transthyretin amyloid cardiomyopathy

R Badr Eslam, B Öztürk, R Rettl… - Circulation: Heart …, 2022 - Am Heart Assoc
Background: In patients with transthyretin amyloid cardiomyopathy, tafamidis was shown to
slow the decline in 6-minute walking distance as compared with placebo. We aimed to define …

Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy

…, L Schrutka, D Dalos, S Charwat-Resl, R Badr Eslam… - Amyloid, 2023 - Taylor & Francis
Aims The impact of tafamidis on myocardial strain in patients with transthyretin amyloid
cardiomyopathy (ATTR-CM) have been barely investigated. We aimed to determine tafamidis-…

Reduction in 99mTc-DPD myocardial uptake with therapy of ATTR cardiomyopathy

…, S Kastl, C Hengstenberg, R Badr Eslam… - Amyloid, 2024 - Taylor & Francis
Aims: Novel ribonucleic acid interference (RNAi) therapeutics such as patisiran and inotersen
have been shown to benefit neurologic disease course and quality of life in patients with …

[HTML][HTML] Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST)

…, N Rassoulpour, C Krall, B Litschauer, R Badr Eslam - Plos one, 2023 - journals.plos.org
… Roza Badr Eslam … six-minute walk distance (6MWD) using the Spearman’s rank correlation
coefficient (r s ). A correlation coefficient ≥ 0.5 was considered as supportive for convergent …

[HTML][HTML] Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis

…, R Kain, C Hengstenberg, R Badr Eslam… - Clinical Research in …, 2021 - Springer
… Roza Badr Eslam … Seirer, Luciana Camuz Ligios, Fabian Dusik, Christophe Capelle, Hong
Qin, Christian Hengstenberg, Roza Badr Eslam & Diana Bonderman … Roza Badr Eslam

Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis

…, F Duca, D Dalos, TM Dachs, C Binder, R Badr-Eslam… - Heart, 2022 - heart.bmj.com
R-wave peaks (R-peak timing) was correlated with the activation maps, and the amplitude
of the R-… , Massachusetts, USA) and we performed factor analysis of mixed data in R V.4.0.2 (…